Risk Stratification for Ventricular Arrhythmias and Scd Role of Cardiac Magnetic Resonance Imaging in the Management and Treatment of Ventricular Tachycardia in Patients with Structural Heart Disease

Treatment for ventricular tachycardia (VT) generally includes 1 or more of the following options: antiarrhythmic therapy, an implantable cardioverter-defibrillator and/or catheter ablation. Catheter ablation is performed with an electroanatomic mapping system to define the heart's 3D anatomy, as well as regions of scar. Radiofrequency energy is then applied to areas of abnormal substrate within which are located channels critical to the VT circuit. Cardiac magnetic resonance (CMR) imaging is a non-invasive modality that provides high-resolution images of cardiac structure and function. CMR has become a very useful tool for sudden cardiac death risk stratification and to facilitate successful radiofrequency ablation of VT in patients with abnormal cardiac substrate. The role of CMR in the management and treatment of VT in patients with structural heart disease is reviewed.

[1]  Matthias Gutberlet,et al.  Feasibility of real-time magnetic resonance imaging-guided electrophysiology studies in humans. , 2013, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[2]  R. Kim,et al.  Detection of Myocardial Damage in Patients With Sarcoidosis , 2009, Circulation.

[3]  F. Marchlinski,et al.  Epicardial Ablation of VT in Patients with Nonischemic LV Cardiomyopathy. , 2010, Cardiac electrophysiology clinics.

[4]  Joel Stein,et al.  Executive summary: heart disease and stroke statistics--2014 update: a report from the American Heart Association. , 2014, Circulation.

[5]  J. Brugada,et al.  Use of myocardial scar characterization to predict ventricular arrhythmia in cardiac resynchronization therapy. , 2012, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[6]  F. Marchlinski,et al.  ECG Criteria to Identify Epicardial Ventricular Tachycardia in Nonischemic Cardiomyopathy , 2010, Circulation. Arrhythmia and electrophysiology.

[7]  M. Cohen,et al.  Determinants of ventricular tachycardia in patients with coronary artery disease and ventricular aneurysm. Clinical, hemodynamic, and angiographic factors. , 1983, American Journal of Cardiology.

[8]  Sanghamitra Mohanty,et al.  Endo-epicardial homogenization of the scar versus limited substrate ablation for the treatment of electrical storms in patients with ischemic cardiomyopathy. , 2012, Journal of the American College of Cardiology.

[9]  Katja Zeppenfeld,et al.  Epicardial substrate mapping for ventricular tachycardia ablation in patients with non-ischaemic cardiomyopathy: a new algorithm to differentiate between scar and viable myocardium developed by simultaneous integration of computed tomography and contrast-enhanced magnetic resonance imaging. , 2013, European heart journal.

[10]  Carissa G. Fonseca,et al.  Rationale and Design for the Defibrillators to Reduce Risk by Magnetic Resonance Imaging Evaluation (DETERMINE) Trial , 2009, Journal of cardiovascular electrophysiology.

[11]  W. Stevenson,et al.  Characterization of the Peri-Infarct Zone by Contrast-Enhanced Cardiac Magnetic Resonance Imaging Is a Powerful Predictor of Post–Myocardial Infarction Mortality , 2006, Circulation.

[12]  F. Marchlinski,et al.  Linear ablation lesions for control of unmappable ventricular tachycardia in patients with ischemic and nonischemic cardiomyopathy. , 2000, Circulation.

[13]  Freddy Odille,et al.  Electroanatomic characterization of post-infarct scars comparison with 3-dimensional myocardial scar reconstruction based on magnetic resonance imaging. , 2008, Journal of the American College of Cardiology.

[14]  W. Manning,et al.  Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance. , 2008, Journal of the American College of Cardiology.

[15]  Arnold Einhorn,et al.  Cardiac magnetic resonance imaging: infarct size is an independent predictor of mortality in patients with coronary artery disease. , 2011, Magnetic resonance imaging.

[16]  Benoit Desjardins,et al.  Endocardial Unipolar Voltage Mapping to Detect Epicardial Ventricular Tachycardia Substrate in Patients With Nonischemic Left Ventricular Cardiomyopathy , 2011, Circulation. Arrhythmia and electrophysiology.

[17]  K. Pointon,et al.  Cardiac magnetic resonance imaging , 2004, Postgraduate Medical Journal.

[18]  Katja Zeppenfeld,et al.  Head-to-head comparison of contrast-enhanced magnetic resonance imaging and electroanatomical voltage mapping to assess post-infarct scar characteristics in patients with ventricular tachycardias: real-time image integration and reversed registration. , 2011, European heart journal.

[19]  Igor Klem,et al.  Assessment of myocardial scarring improves risk stratification in patients evaluated for cardiac defibrillator implantation , 2011, Journal of the American College of Cardiology.

[20]  J. Brugada,et al.  Integration of 3D Electroanatomic Maps and Magnetic Resonance Scar Characterization Into the Navigation System to Guide Ventricular Tachycardia Ablation , 2011, Circulation. Arrhythmia and electrophysiology.

[21]  S. Abbara.  Late Gadolinium Enhancement by Cardiovascular Magnetic Resonance Heralds an Adverse Prognosis in Nonischemic Cardiomyopathy , 2009 .

[22]  Benoit Desjardins,et al.  Delayed-enhanced magnetic resonance imaging in nonischemic cardiomyopathy: utility for identifying the ventricular arrhythmia substrate. , 2009, Journal of the American College of Cardiology.

[23]  Timm Dickfeld,et al.  MRI-Guided Ventricular Tachycardia Ablation: Integration of Late Gadolinium-Enhanced 3D Scar in Patients With Implantable Cardioverter-Defibrillators , 2011, Circulation. Arrhythmia and electrophysiology.

[24]  Thomas C. Crawford,et al.  Implantable Cardioverter Defibrillator Therapy in Patients with Cardiac Sarcoidosis , 2012, Journal of cardiovascular electrophysiology.

[25]  Sebastian Kelle,et al.  Prognostic value of myocardial infarct size and contractile reserve using magnetic resonance imaging. , 2009, Journal of the American College of Cardiology.

[26]  Daniel C. Lee,et al.  Infarct size by contrast enhanced cardiac magnetic resonance is a stronger predictor of outcomes than left ventricular ejection fraction or end-systolic volume index: prospective cohort study , 2007, Heart.

[27]  U. Kramer,et al.  CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis. , 2013, JACC. Cardiovascular imaging.

[28]  Wojciech Zareba,et al.  Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. , 2002, The New England journal of medicine.

[29]  A. Khasnis,et al.  Prophylactic Defibrillator Implantation in Patients With Nonischemic Dilated Cardiomyopathy , 2004 .

[30]  R. Califf,et al.  Sustained ventricular arrhythmias in patients receiving thrombolytic therapy: incidence and outcomes. The GUSTO Investigators. , 1998, Circulation.

[31]  F. Marchlinski,et al.  Twelve-lead ECG features to identify ventricular tachycardia arising from the epicardial right ventricle. , 2006, Heart rhythm.

[32]  A. d'Avila,et al.  A New Technique to Perform Epicardial Mapping in the Electrophysiology Laboratory , 1996, Journal of cardiovascular electrophysiology.

[33]  R. Gerszten,et al.  What is the risk of sudden cardiac death in patients presenting with hemodynamically stable sustained ventricular tachycardia after myocardial infarction? , 1996, Journal of the American College of Cardiology.

[34]  Joshua J. E. Blauer,et al.  Identification and Acute Targeting of Gaps in Atrial Ablation Lesion Sets Using a Real-Time Magnetic Resonance Imaging System , 2012, Circulation. Arrhythmia and electrophysiology.

[35]  J. Brugada,et al.  Usefulness of contrast-enhanced cardiac magnetic resonance in identifying the ventricular arrhythmia substrate and the approach needed for ablation. , 2014, European heart journal.

[36]  David V. Daniels,et al.  Idiopathic Epicardial Left Ventricular Tachycardia Originating Remote From the Sinus of Valsalva: Electrophysiological Characteristics, Catheter Ablation, and Identification From the 12-Lead Electrocardiogram , 2006, Circulation.

[37]  Raymond J Kim,et al.  Infarct morphology identifies patients with substrate for sustained ventricular tachycardia. , 2005, Journal of the American College of Cardiology.

[38]  Katja Zeppenfeld,et al.  Infarct Tissue Heterogeneity Assessed With Contrast-Enhanced MRI Predicts Spontaneous Ventricular Arrhythmia in Patients With Ischemic Cardiomyopathy and Implantable Cardioverter-Defibrillator , 2009, Circulation. Cardiovascular imaging.

[39]  W. Dassen,et al.  Cardiac involvement in patients with pulmonary sarcoidosis assessed at two university medical centers in the Netherlands. , 2005, Chest.

[40]  R. Ideker,et al.  Quantitative analysis of myocardial infarct structure in patients with ventricular tachycardia. , 1986, Circulation.

[41]  Douglas L Packer,et al.  Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. , 2005, The New England journal of medicine.

[42]  F. Marchlinski,et al.  Site-specific twelve-lead ECG features to identify an epicardial origin for left ventricular tachycardia in the absence of myocardial infarction. , 2007, Heart rhythm.

[43]  D. Lin,et al.  Isolated septal substrate for ventricular tachycardia in nonischemic dilated cardiomyopathy: incidence, characterization, and implications. , 2011, Heart rhythm.

[44]  Antonio Berruezo,et al.  Electrocardiographic Recognition of the Epicardial Origin of Ventricular Tachycardias , 2004, Circulation.

[45]  Hiroshi Ashikaga,et al.  The critical isthmus sites of ischemic ventricular tachycardia are in zones of tissue heterogeneity, visualized by magnetic resonance imaging. , 2011, Heart rhythm.

[46]  R. Muthupillai,et al.  The utility of delayed-enhancement magnetic resonance imaging for identifying nonischemic myocardial fibrosis in asymptomatic patients with biopsy-proven systemic sarcoidosis. , 2009, Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG.